Nu-Med Plus (NUMD) Capital Expenditures Growth (1y) (2013 - 2014)
Nu-Med Plus (NUMD) Capital Expenditures Growth (1y) (2013 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | -6.52% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -104.04% |
| Dec 31, 2013 | 75,766.67% |
| Sep 30, 2013 | 167,800.00% |